It is a prospective observational study. Patients will be high risk patients (for developing cardiovascular events) that are treated with a statin. Patients will be enrolled at a normal clinic visit and provided with a small box containing info about the disease, a LDL self-test and two questionnaires. They will test themselves for LDL at home between normal clinic visits (normally 12 months interval) and note their value. In the end of the study all patients will fill out a questionnaire with questions if the tests and info have raised their awareness of the disease as well if their motivation to be compliant has increased. We want to look at the possibility to put more responsibility for treatment and for reaching treatment goals on the patients since there's a big problem with compliance in this group of patients.
Consecutive patient sampling
Study Type
OBSERVATIONAL
Enrollment
259
Self test for lipid levels, twice during study period
Pfizer Investigational Site
Åkersberga, Sweden
Pfizer Investigational Site
Forshaga, Sweden
Pfizer Investigational Site
Gothenburg, Sweden
Pfizer Investigational Site
Gothenburg, Sweden
Pfizer Investigational Site
Gothenburg, Sweden
Pfizer Investigational Site
Höganäs, Sweden
Pfizer Investigational Site
Jönköping, Sweden
Pfizer Investigational Site
Lessebo, Sweden
Pfizer Investigational Site
Lilla Edet, Sweden
Pfizer Investigational Site
Limhamn, Sweden
...and 7 more locations
Percentage of Participants With Positive Response on Increased Motivation Using a Self-test at Month 12
Participants with "Yes" response to a question which stated "The self-test have increased my motivation for taking my medication for hyperlipidemia?". The self test done for assessment of LDL levels using CARE diagnostica LDL-cholesterol test.
Time frame: Month 12
Percentage of Participants With Positive Response on Increased Motivation After Awareness at Month 12
Participants with "Yes" response to a question which stated "The awareness of my disease has increased my motivation for taking my medication for hyperlipidemia?".
Time frame: Month 12
Percentage of Participants With Positive Response on Self-estimated Treatment Compliance at Week 8
Participants with "Yes" response to a question which stated "Have you been taking at least 90% of your medication for hyperlipidemia?".
Time frame: Week 8
Percentage of Participants With Positive Response on Self-estimated Treatment Compliance at Month 6
Participants with "Yes" response to a question which stated "Have you been taking at least 90% of your medication for hyperlipidemia?".
Time frame: Month 6
Percentage of Participants With Positive Response on Self-estimated Treatment Compliance at Month 12
Participants with "Yes" response to a question which stated "Have you been taking at least 90% of your medication for hyperlipidemia?".
Time frame: Month 12
Percentage of Participants With LDL Lower Than 2.5 mmol/L at Week 8
LDL levels were self-assessed by participants using CARE diagnostica LDL-cholesterol test.
Time frame: Week 8
Percentage of Participants With LDL Lower Than 2.5 mmol/L at Month 6
LDL levels were self-assessed by participants using CARE diagnostica LDL-cholesterol test.
Time frame: Month 6
Percentage of Participants With LDL Lower Than 2.5 mmol/L at Month 12
LDL levels were self-assessed by participants using CARE diagnostica LDL-cholesterol test.
Time frame: Month 12
Percentage of Participants With Response Achieving Targeted LDL-cholesterol Level at Week 8
Participants with "Yes" or "No" responses to a question which stated "Have you reached your target LDL-cholesterol level?". LDL levels were self-assessed by participants using CARE diagnostica LDL-cholesterol test.
Time frame: Week 8
Percentage of Participants With Response Achieving Targeted LDL-cholesterol Level at Month 6
Participants with "Yes" or "No" responses to a question which stated "Have you reached your target LDL-cholesterol level?". LDL levels were self-assessed by participants using CARE diagnostica LDL-cholesterol test.
Time frame: Month 6
Percentage of Participants With Response Achieving Targeted LDL-cholesterol Level at Month 12
Participants with "Yes" or "No" responses to a question which stated "Have you reached your target LDL-cholesterol level?". LDL levels were self-assessed by participants using CARE diagnostica LDL-cholesterol test.
Time frame: Month 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.